Table 1.
Primers | Direction | Sequences |
---|---|---|
TNF- | Forward | 5′-AGCAAACCACCAAGTGGAGGA-3′ |
Reverse | 5′-GCTGGCACCACTAGTTGGTTGT-3′ | |
CCL-2 | Forward | 5′-GAAGGAATGGGTCCAGACAT-3′ |
Reverse | 5′-ACGGGTCAACTTCACATTCA-3′ | |
IL-6 | Forward | 5′-GCTACCAAACTGGATATAATCAGGA-3′ |
Reverse | 5′-CCAGGTAGCTATGGTACTCCAGAA-3′ | |
IL-10 | Forward | 5′-ACTGGCATGAGGATCAGCAG-3′ |
Reverse | 5′-CTCCTTGATTTCTGGGCCAT-3′ | |
18s | Forward | 5′-GCAATTATTCCCCATGAACG-3′ |
Reverse | 5′-GGCACTTAATCAACGCAAGC-3′ |
TNF-, tumor necrosis factor-alpha; CCL-2, C-C motif chemokine ligand-2; IL-6, interleukin-6; IL-10, interleukin-10; 18 s, 18 s rRNA.